Am J Perinatol
DOI: 10.1055/s-0043-1778065
Original Article

Pneumoprotein CC16 in the Umbilical Cord Blood of Preterm Neonates

Dimitrios Rallis
1   Department of Pediatrics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
2   Neonatal Intensive Care Unit, University of Ioannina, Faculty of Medicine, Ioannina, Greece
,
Aimilia Eirini Papathanasiou
1   Department of Pediatrics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Helen Christou
1   Department of Pediatrics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Funding None.

Abstract

Objective We examined the impact of perinatal factors on cord serum club cell protein (CC16) and the association of CC16 with mechanical ventilation and bronchopulmonary dysplasia (BPD) in preterm neonates.

Study Design A retrospective cohort study including 60 neonates born with gestational age (GA) < 34 weeks. The impact of categorical perinatal factors on cord blood levels of CC16 was examined with univariate and multivariate regression analyses.

Results In neonates with GA < 32 weeks, cord blood CC16 concentrations were significantly lower compared to neonates with GA between 320/7 and 336/7 weeks (5.4 ± 2.5 compared to 7.6 ± 2.9 ng/mL, p = 0.039). Neonates with prolonged rupture of membranes had significantly lower CC16 compared to those without prolonged rupture of membranes (4.0 ± 1.9 compared to 7.2 ± 2.2, p < 0.001). Finally, neonates with BPD had significantly lower CC16, compared to neonates without BPD (4.2 ± 2.1 compared to 7.0 ± 2.2 ng/mL, p = 0.004).

Prolonged rupture of membranes was significantly negatively associated with CC16 (b = −2.67, 95% confidence interval [CI] −0.49 to −4.85, p = 0.017), after adjusting for GA (b = 0.23, 95% CI 0.03–0.42, p = 0.022), mode of conception, and mode of delivery. Finally, higher CC16 levels were significantly inversely associated with BPD (odds ratio = 0.33, 95% CI 0.12–0.88, p = 0.028), after adjusting for GA (b = 0.27, 95% CI 0.09–0.78, p = 0.015), and birth weight.

Conclusion Prolonged rupture of membranes was significantly negatively associated with cord serum CC16, after adjusting for GA, conception, and delivery mode, and CC16 was significantly inversely associated with BPD, after adjusting for GA and birth weight.

Key Points

  • Neonates with prolonged rupture of membranes had lower CC16 levels.

  • CC16 was significantly negatively associated with BPD.

  • CC16 could be a biomarker of lung injury and BPD.

Authors' Contributions

D.R. and H.C. conceptualized and developed the study design. Data collection was performed by D.R. and A.E.P. A.E.P. performed the ELISA measurements. D.R. performed the statistical analysis and wrote the initial draft. A.E.P. and H.C. critically reviewed and revised the manuscript. All authors approved the final manuscript and agreed to be accountable for all aspects of the work.


Ethical Approval

The study was approved by the institutional review board (Protocol Number 2012P000384/02.10.2012) and exempted from requiring written informed consent. The study was performed in accordance with the Declaration of Helsinki.




Publication History

Received: 11 July 2023

Accepted: 11 December 2023

Article published online:
31 December 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Stoll BJ, Hansen NI, Bell EF. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010; 126 (03) 443-456
  • 2 Horbar JD, Carpenter JH, Badger GJ. et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 2012; 129 (06) 1019-1026
  • 3 Vento M, Moro M, Escrig R. et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 2009; 124 (03) e439-e449
  • 4 McColm JR, McIntosh N. Interleukin-8 in bronchoalveolar lavage samples as predictor of chronic lung disease in premature infants. Lancet 1994; 343 (8899) 729
  • 5 An H, Nishimaki S, Ohyama M. et al. Interleukin-6, interleukin-8, and soluble tumor necrosis factor receptor-I in the cord blood as predictors of chronic lung disease in premature infants. Am J Obstet Gynecol 2004; 191 (05) 1649-1654
  • 6 McColm JR, Stenson BJ, Biermasz N, McIntosh N. Measurement of interleukin 10 in bronchoalveolar lavage from preterm ventilated infants. Arch Dis Child Fetal Neonatal Ed 2000; 82 (02) F156-F159
  • 7 Klinger G, Levy I, Sirota L, Boyko V, Lerner-Geva L, Reichman B. Israel Neonatal Network. Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics 2010; 125 (04) e736-e740
  • 8 Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM. North Carolina Neonatologists Association. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics 1999; 104 (06) 1345-1350
  • 9 Perrone S, Toti P, Toti MS. et al. Perinatal outcome and placental histological characteristics: a single-center study. J Matern Fetal Neonatal Med 2012; 25 (Suppl. 01) 110-113
  • 10 Kropski JA, Fremont RD, Calfee CS, Ware LB. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest 2009; 135 (06) 1440-1447
  • 11 Sarafidis K, Stathopoulou T, Diamanti E. et al. Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates. Eur J Pediatr 2008; 167 (11) 1297-1303
  • 12 Bernard A, Roels H, Lauwerys R. et al. Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions. Clin Chim Acta 1992; 207 (03) 239-249
  • 13 Guy J, Dhanireddy R, Mukherjee AB. Surfactant-producing rabbit pulmonary alveolar type II cells synthesize and secrete an antiinflammatory protein, uteroglobin. Biochem Biophys Res Commun 1992; 189 (02) 662-669
  • 14 Lesur O, Bernard A, Arsalane K. et al. Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 1995; 152 (01) 290-297
  • 15 Loughran-Fowlds A, Oei J, Wang H. et al. The influence of gestation and mechanical ventilation on serum clara cell secretory protein (CC10) concentrations in ventilated and nonventilated newborn infants. Pediatr Res 2006; 60 (01) 103-108
  • 16 Loughran-Fowlds AS, Lin JW, Oei J, Michalowski J, Henry R, Lui K. Early postnatal surge of serum Clara cell secretory protein in newborn infants. Neonatology 2012; 101 (02) 125-131
  • 17 Schrama AJ, Bernard A, Poorthuis BJ, Zwinderman AH, Berger HM, Walther FJ. Cord blood Clara cell protein CC16 predicts the development of bronchopulmonary dysplasia. Eur J Pediatr 2008; 167 (11) 1305-1312
  • 18 Higgins RD, Jobe AH, Koso-Thomas M. et al. Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr 2018; 197: 300-308
  • 19 Briana DD, Gourgiotis D, Boutsikou M. et al. Clara cell protein in full-term pregnancies: the influence of intrauterine growth restriction. Pediatr Pulmonol 2010; 45 (12) 1186-1191
  • 20 Dierynck I, Bernard A, Roels H, De Ley M. Potent inhibition of both human interferon-gamma production and biologic activity by the Clara cell protein CC16. Am J Respir Cell Mol Biol 1995; 12 (02) 205-210
  • 21 Bernard A, Thielemans N, Lauwerys R, Langhendries JP, Van Lierde M, Freund MM. Clara cell protein in human amniotic fluid: a potential marker of fetal lung growth. Pediatr Res 1994; 36 (06) 771-775
  • 22 Thomas W, Seidenspinner S, Kawczyńska-Leda N. et al. Clara cell secretory protein in tracheobronchial aspirates and umbilical cord serum of extremely premature infants with systemic inflammation. Neonatology 2010; 97 (03) 228-234
  • 23 Lassus P, Nevalainen TJ, Eskola JU, Andersson S. Clara-cell secretory protein in preterm infants' tracheal aspirates correlates with maturity and increases in infection. Pediatr Pulmonol 2000; 30 (06) 466-469
  • 24 Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000; 19 (03) 348-352
  • 25 Li H, Niederkorn JY, Neelam S. et al. Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 2005; 46 (03) 900-907
  • 26 Gomez-Lopez N, Estrada-Gutierrez G, Jimenez-Zamudio L, Vega-Sanchez R, Vadillo-Ortega F. Fetal membranes exhibit selective leukocyte chemotaxic activity during human labor. J Reprod Immunol 2009; 80 (1-2): 122-131
  • 27 Arechavaleta-Velasco F, Ogando D, Parry S, Vadillo-Ortega F. Production of matrix metalloproteinase-9 in lipopolysaccharide-stimulated human amnion occurs through an autocrine and paracrine proinflammatory cytokine-dependent system. Biol Reprod 2002; 67 (06) 1952-1958
  • 28 Rallis D, Baltogianni M, Dermitzaki N. et al. Club cell protein expression amongst infants with respiratory distress syndrome. Pediatr Pulmonol 2022; 57 (06) 1543-1546
  • 29 Levine CR, Gewolb IH, Allen K. et al. The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome. Pediatr Res 2005; 58 (01) 15-21
  • 30 Davis JM, Pilon AL, Shenberger J. et al. The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity. Pediatr Res 2019; 86 (02) 254-260